Food and Drug Administration
Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)
Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01) is a funding opportunity from Food and Drug Administration, up to 350000.
Overview
The Food and Drug Administration's (FDA), Center for Drug Evaluation and Research (CDER), Office of New Drugs (OND), is announcing this Funding Opportunity Announcement (FOA) for a Cooperative Agreement. The proposed work directly supports the U.S. FDA’s stated goal of protecting public health from unacceptable…